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The solution structure of the bovine S100B protein dimer in the
calcium-free state
Peter M Kilby1*, Linda J Van Eldik2 and Gordon CK Roberts1
Background:  S100B (S100b) is a member of the S100 family of small calcium-
binding proteins: members of this family contain two helix-loop-helix calcium-
binding motifs and interact with a wide range of proteins involved mainly in the
cytoskeleton and cell proliferation. S100B is a neurite-extension factor and levels
of S100B are elevated in the brains of patients with Alzheimer’s disease or
Down’s syndrome: the pattern of S100B overexpression in Alzheimer’s disease
correlates with the pattern of neuritic-plaque formation. Identification of a growing
class of S100 proteins and the likely neurochemical importance of S100B make
the determination of the structure of S100B of interest.
Results:  We have used NMR to determine the structure of the reduced S100B
homodimer in the absence of calcium. Each monomer consists of a four-helix
bundle, arranged in the dimer in an antiparallel fashion. The fourth helix of each
monomer runs close to the equivalent helix of the other monomer for almost its full
length, extending the hydrophobic core through the interface. The N-terminal, but
not the C-terminal, calcium-binding loop is similar to the equivalent loop in the
monomeric S100 protein calbindin and is in a conformation ready to bind calcium.
Conclusions:  The novel dimer structure reported previously for calcyclin
(S100A6) is the common fold for the dimeric S100B proteins. Calcium binding to
the C-terminal calcium-binding loop would be expected to require a conformational
change, which might provide a signal for activation. The structure suggests regions
of the molecule likely to be involved in interactions with effector molecules.
Introduction
S100B (S100b) is a member of a group of low molecular
weight (7–11 kDa) acidic calcium-binding proteins that
contain two helix-loop-helix calcium-binding motifs [1–3].
The N-terminal calcium-binding loop is unusual in that it
is composed of 14 amino acids and uses mainly backbone
carbonyl oxygens as calcium ligands. In contrast, the classi-
cal EF-hand contains only 12 amino acids and uses mainly
ligands from the amino acid side chains to coordinate
calcium[4]. S100 proteins also contain hydrophobic regions
at the N and C termini. These regions are conserved
among the members of the group even when their amino
acid sequences are not. The discovery of a gene cluster of
nine S100 proteins led to a new nomenclature [5] for these
proteins (e.g. S100B for S100b) and this is used in the text.
A number of biochemical activities have been reported for
S100B, including effects on cytoskeletal systems, protein
phosphorylation and enzyme activities [6,7]. In addition to
these intracellular functions, a disulphide-linked dimer of
S100B has neurotrophic activity on selected neuronal pop-
ulations and mitogenic and morphogenic activity on astro-
cytes [6,7]. The levels of S100B in the brain are elevated in
Alzheimer’s disease and Down’s syndrome, with S100B
localized primarily in activated astrocytes surrounding neu-
ritic plaques [8]. The pattern of S100B overexpression in
Alzheimer’s disease correlates with the pattern of neuritic-
plaque formation [9], suggesting a possible relationship
between S100B levels and the regional distribution of
Alzheimer neuropathology.
Among the members of the S100 family of proteins, struc-
tural information only exists for calbindin D9k (CALB3,
subsequently referred to as calbindin) and S100A6 (calcy-
clin) [10]. In the case of calbindin, X-ray [11] and NMR
[12–14] structures are available. Calbindin is the protein
least similar to the remainder of the S100 group, sharing
only 27% identity with S100B. It is also somewhat smaller
than the other proteins, lacks the C-terminal hydrophobic
region, and is a monomer in solution whereas the other
S100 proteins are dimers. It is therefore not clear that cal-
bindin provides a satisfactory model for the structures of the
other S100 proteins. The identification of a growing class 
of S100 proteins and the likely neurochemical importance
of S100B make the determination of the structure of S100B
of interest. Two preliminary crystallization notes have
appeared [15,16] but as yet no structure has been reported.
Since we reported the backbone resonance assignments
and secondary structure of bovine S100B [17], these have
been confirmed for rat S100B. [18] An NMR structure,
determined from two-dimensional (2D) homonuclear NMR
data, of S100A6 (calcyclin), another dimeric member of the
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Table 1
Chemical shift* values for S100B at pH 6.5 and 314 K.
Residue Exchange† 15N(1H) 13Ca(1Ha) 13Cb(1Hb) other 13C(1H)
Met0 53.8 33.6 Cε 15.6(1.80)
Ser1‡ 101.4(10.18) 55.9(4.82) 63.6(4.28,4.78)
Glu2 100.0(8.96) 58.3(4.04) 27.4(2.081) Cg (2.44)
Leu3 o 100.5(9.00) 57.0(4.04) 40.4(1.85) Cg 24.5(1.58) Cd 25.5(0.76), 24.2(1.02)
Glu4 • 99.0(8.16) 58.2(3.35) 28.4(2.08,2.27) Cg (2.54)
Lys5# • 96.8(8.45) 58.6(3.89) 31.4(1.87) Cg 24.5(1.64) Cd 27.9(1.75) Cε 38.7(2.89)
Ala6 • 103.1(7.96) 53.4(4.29) 17.2(1.71)
Val7 • 97.8(8.52) 66.0(3.68) 31.7(2.32) Cg 22.6(0.93) Cg 21.2(1.20)
Val8 • 99.3(8.58) 66.0(3.50) 30.2(2.25) Cg (0.99) Cg (1.22)
Ala9 • 102.1(7.65) 53.9(4.29) 16.9(1.65)
Leu10 • 98.8(8.11) 57.8(4.09) 40.6(2.58,1.76) Cg 26.1(2.07) Cd 23.6(0.92), 24.7(0.93)
Ile11 o 99.9(8.58) 64.6(3.39) 27.0(1.75,0.12) Cg2 11.4(0.22) Cg1 27.3(0.15,1.80) Cd1 15.9(0.27)
Asp12 • 100.5(8.35) 56.3(4.43) 39.2(2.79,2.88)
Val13 • 100.5(8.46) 65.2(3.82) 30.2(2.22) Cg 20.4(1.20), 21.8(1.23)
Phe14 • 99.5(8.39) 61.0(3.48) 37.8(3.05,3.14) Cd 130.4(6.25) Cε 129.7(7.07) Cz (7.28)
His15 96.4(8.73) Cd2 (7.30) Cε1 (8.56)
Gln16 • 102.2(8.32) 57.5(3.83) 26.8(2.17,2.41) Cg 33.1(2.62) Nε2 90.4(6.86,7.35)
Tyr17 • 95.0(7.33) 58.7(4.09) 26.6(2.61) Cd 132.4(7.30) Cε 115.9(6.65)
Ser18 100.5(9.57) 58.5(4.00) 59.8(2.43,3.48)
Gly19 86.9(8.04) 43.8(3.71, 3.96)
Arg20 97.9(7.11) 57.3(3.94) 29.1(1.82) Cg (1.57,1.77) Cd (3.16) Nε 65.8(6.76)
Glu21 95.0(7.78) 53.6(4.46) 30.3(1.86,2.15) Cg 33.4(2.21)
Gly22 88.3(8.37) 44.5(3.66,3.85)
Asp23 105.3(8.61) 52.8(4.44) 41.1(2.64)
Lys24 105.7(8.58) 55.8(4.25) 30.2(1.45,1.54) Cg (0.85) Cd 27.1(1.16) Cε 40.4(2.99)
His25 96.7(9.16) 53.5(4.91) 28.3(3.25,3.67) Cd2 119.4(7.19)
Lys26 96.9(7.66) 52.8(5.29) 36.3(1.72) Cg 23.6(1.27) Cd 27.6(1.48,1.70) Cε 40.7(3.00)
Leu27 o 99.4(8.62) 51.5(4.82) 44.6(1.37,1.46) Cg 27.4(1.38) Cd 24.5(0.56), 25.0(0.56)
Lys28 o 103.2(9.21) 54.9(4.83) 32.0(1.67,2.33) Cg 24.5(1.54) Cd 27.6(1.72) Cε 40.4(2.98)
Lys29 o 105.9(9.06) 60.3(3.76) 29.9(2.30) Cg 28.5(1.11,1.45) Cd(1.74) Cε(2.78)
Ser30 93.4(9.28) 59.5(4.14) (2.85,3.11)
Glu31 o 103.6(7.04) 56.6(4.33) 28.9(2.33,2.52) Cg 35.8(2.03,2.26)
Leu32 • 101.9(8.34) 55.5(3.96) 39.1(1.30,2.10) Cg 30.3(1.44) Cd 25.6(0.80), 23.3(1.13)
Lys33 • 99.6(8.04) 59.1(3.47) 30.8(1.62,1.96) Cg 23.3(1.40) Cd 27.9(1.67) Cε 40.4(2.88)
Glu34 o 98.0(6.95) 57.7(3.98) 28.2(2.27) Cg 34.3(2.48)
Leu35 • 101.8(8.08) 58.0(3.42) 40.6(0.79,1.61) Cg(0.81) Cd 26.5(0.40), 21.8 (0.60)
Ile36 • 100.5(8.55) 64.3(3.20) 36.5(1.76) Cg2 27.7(0.78) Cg1(1.43) Cd1 11.9(0.55)
Asn37 • 95.1(7.89) 54.5(4.19) 36.9(2.54,2.69) Nd2 88.7(6.30,7.18)
Asn38 • 94.4(8.35) 53.5(4.65) 38.1(2.74,3.05) Nd2 91.1(7.07,7.57)
Glu39 • 94.2(9.05) 54.2(4.89) 29.4(1.71,2.39)
Leu40 • 98.6(7.82) 52.4(5.06) 39.2(1.78,2.03) Cg (1.44) Cd 23.3(0.63), 25.3(0.79)
Ser41 o 91.7(6.81) 60.2(3.83) 61.4(3.86,4.06)
His42 102.3(9.73) 58.0(4.64) 25.6(3.33,3.56) Cd2 117.8(7.12) Cε1 (8.43)
Phe43 o 102.4(8.25) 56.9(4.48) 35.2(3.24,3.35) Cd 128.5(7.13) Cε 129.8(7.34) Cz(7.27)
Leu44 • 94.8(8.15) 55.5(4.03) 39.8(1.58,1.73) Cg 25.3(1.58) Cd1 21.5(0.78), 24.5(0.78)
Glu45 o 97.7(7.34) 56.3(4.19) 28.9(2.19,2.21) Cg (1.74,1.95)
Glu46 98.3(7.59) 53.3(4.55) 28.5(1.97,2.19) Cg 33.4(2.25)
Ile47 101.3(7.70) 61.0(3.97) 37.2(1.79) Cg2 16.0(0.75) Cg1 26.5(1.11,1.78) Cd1 12.3(0.90)
Lys48 106.7(8.70) 55.3(4.40) 31.7(1.74) Cg 23.0(1.31) Cd 27.1(1.44) Cε 40.4(2.72)
Glu49 99.4(7.69) 52.6(4.74) 27.6(1.95,2.17) Cg 33.7(2.21,2.28)
Gln50 105.5(8.51) 57.0(3.68) 27.3(1.95,2.12) Cg 31.7(2.38,2.42) Nε2 93.5(6.602,7.86)
Glu51 96.7(9.13) 58.0(4.08) 27.3(2.03) Cg 34.9(2.33)
Val52 97.8(7.14) 64.5(3.64) 30.3(2.07) Cg 19.4(0.83), 20.7(1.01)
Val53 o 98.8(6.81) 65.5(3.32) 30.0(2.09) Cg 19.5(0.89), 21.8(0.89)
Asp54 o 99.3(8.54) 56.0(4.26) 38.4(2.64)
Lys55 o 99.5(7.81) 57.4(4.12) 30.3(1.97) Cg 23.3(1.51) Cd 27.5(1.67) Cε 40.4(2.94)
Val56 o 102.1(8.07) 65.7(3.61) 30.0(2.31) Cg (0.83), 21.8(1.16)
Met57 o 96.2(8.41) 56.1(4.08) 29.4(2.29) Cg 31.7(2.78,2.88) Cε 16.4(1.95)
Glu58 o 98.6(8.30) 57.8(4.05) 29.4(2.13) Cg 34.9(1.80)
Thr59 o 96.6(8.03) 65.0(3.95) 67.0(4.45) Cg 2 19.8(1.36)
Leu60 o 101.0(7.84) 55.9(3.90) 38.7(1.28,1.70) Cg 24.5(1.67) Cd 20.4(0.22), 24.2(0.42)
Asp61 o 96.4(8.07) 54.5(4.41) 39.6(2.62)
S100 family of proteins, has recently been published and
revealed a novel dimeric fold [10]. 
We now report the full 3D structure of the reduced,
calcium-free S100B dimer, calculated from 3D NMR data.
The structure consists of two four-helix-bundle monomers
which interact with each other in an antiparallel manner.
The fourth helix of each monomer runs close to the equiv-
alent helix on the other monomer for almost the whole of
its length. We find that the N-terminal calcium-binding
loop is preformed, ready to bind calcium, but that the C-
terminal loop would need to change conformation before
calcium could bind.
Results
Resonance assignment and structure calculation
The structure of bovine calcium-free S100B protein in
solution was determined using constraints derived from
3D NMR data. The assignment of the backbone 1H and
15N and most of the side chain 1H chemical shifts has
been reported previously [17]. Four additional 3D experi-
ments, CBCA(CO)NH (an experiment which correlates
the 13Ca and 13Cb chemical shifts of one residue with the
15N and 1H chemical shifts of the succeeding residue),
HNCA (which correlates the 13Ca shift with the 15N and
1H chemical shifts of the same residue), 13C-edited
NOESY-HMQC (nuclear Overhauser effect spectroscopy-
heteronuclear multiple quantum coherence) and HCCH-
TOCSY (total correlation spectroscopy with coherence
transfer through proton–carbon and carbon–carbon cou-
plings), on (13C,15N)-labelled protein have now been used
to confirm the 1H assignments already made and to permit
the assignment of the 13C nuclei of S100B. Using this
approach, assignments of 1H, 15N and 13C resonances were
obtained for all of the 92 residues except Met0, His85,
Glu86 and the backbone atoms of Phe87 and His90. The
full list of assignments is given in Table 1.
The structure determination of a homodimer such as
S100B is hampered by the fact that it is impossible to dis-
tinguish unequivocally between the inter- and intra-
monomer NOEs without resorting to asymmetric labelling.
The problem is exacerbated by the ambiguity of many
assignments of NOESY crosspeaks in 3D NOESY-HMQC
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Table 1 (continued)
Residue Exchange† 15N(1H) 13Ca(1Ha) 13Cb(1Hb) other 13C(1H)
Ser62 93.7(7.82) 58.6(4.32) 62.0(3.98)
Asp63 101.0(7.28) 51.5(4.99) 40.0(2.34,2.52)
Gly64 87.6(8.01) 46.3(3.84,3.91)
Asp65 95.5(8.13) 52.7(4.89) 39.9(2.57,2.80)
Gly66 89.1(8.08) 43.7(3.84,4.11)
Glu67 98.5(8.47) 54.2(5.00) 32.0(1.95,2.34) Cg 35.5(2.07,2.37)
Cys68 o 99.8(9.37) 55.8(5.15) 29.6(2.69,3.03)
Asp69 o 102.8(8.58) 50.2(5.30) 41.0(2.71,3.56)
Phe70 99.1(9.25) 60.3 38.5 Cd 130.0(7.04) Cε 131.0(7.28) Cz 127.9(7.31)
Gln71 o 97.2(8.00) 58.4(3.42) 26.5(2.08,2.12) Cg 32.9(2.20) Nε2 90.5(6.77,7.10)
Glu72 102.0(8.37) 58.0(3.96) 28.7(2.30) Cg 35.5(2.46)
Phe73 100.7(8.51) 59.3(4.35) 37.3(3.20,3.50) Cd 131.3(6.86) Cε 126.9(7.06)
Met74 • 98.4(7.92) 56.8(3.16) 30.2(1.71,1.31) Cg 32.7 Cε 15.6(1.70)
Ala75 • 101.8(7.56) 53.2(3.97) 16.0(1.23)
Phe76 • 98.0(8.19) 60.8(4.29) 37.4(2.79,3.05) Cd 130.7(7.26) Cε 129.8(7.47) Cz (7.15)
Val77 • 98.6(8.25) 65.7(3.21) 29.6(1.68) Cg 21.6(0.29), 20.1(0.59)
Ala78 • 104.2(8.58) 54.3(3.94) 17.8(1.40)
Met79 • 97.6(7.96) 57.8(3.88) 32.0(1.86,2.15) Cg 30.5(2.41,2.60) Cε 16.1(2.11)
Ile80 • 96.8(7.82) 61.7(3.57) 35.2(2.03) Cg2 16.0(0.89) Cg1 16.5(1.54) Cd1 10.0(0.74)
Thr81 • 95.5(8.26) 67.4(3.61) 66.4(4.31) Cg2 20.3(0.90)
Thr82 • 89.8(7.72) 62.8(3.29) 66.8(3.91) Cg2 20.0(0.68)
Ala83 o 101.0(7.30) 50.7(4.44) 18.4(1.60)
Cys84 96.1(7.56) 53.5(4.69) 28.1(2.75,2.86)
His85
Glu86
Phe87 Cd 128.9(6.97) Cε 130.2(6.23) Cz (7.13)
Phe88 93.5(7.45) 57.0(3.99) 38.1(2.90,3.27) Cd 130.3(6.19) Cε 128.8(6.53) Cz 127.6(6.99)
Glu89 99.2(7.58) 53.8(4.19) 28.5(1.79,2.16) Cg 34.3(2.61)
His90 Cd2 (7.30) Cε1 (8.39)
Glu91 107.1(8.11) 56.5(4.01) (1.84,2.16)
*1H chemical shifts were referenced to a trimethylsilylpropionic acid
standard in a concentric capillary in the NMR tube, 15N chemical shifts
to an external standard of 15NH4NO3 in 1M nitric acid and 13C shifts to
an external standard of tetramethylsilane. †Amides that exchanged in
> 0.3 h and < 14 h are shown as o and those which had not exchanged
after 14 h are shown as •. ‡Ser1 also shows a second smaller HN
resonance at 100.2 (9.92). #Resonances of Lys5, Ser41 and Glu45
are split into two overlapping components in 15N–1H HSQC spectra.
Chemical shifts are given for the largest resonance.
experiments in which several nuclei have similar chemical
shifts. These difficulties have caused us to use a method
for structure calculation that incorporates a treatment of
ambiguity into the NOESY crosspeak assignments [19]
and in whether NOEs are intra- or intermonomer [20].
Three 3D NOESY-HMQC datasets were used to derive
the constraints used in the calculation of the structure.
The constraints were derived by determination of the
NOE volumes, as described in the Materials and methods
section. A family of S100B monomer structures was calcu-
lated using only the uniquely assigned intramonomer con-
straints. The monomers with the lowest energy were
duplicated and docked to form dimers using simulated
annealing, gradually increasing the weight of the uniquely
assigned intermonomer NOE constraints. The identities
of the ambiguous NOE restraints were then determined
by iteration through the structure determination protocol.
The backbones of the 25 lowest-energy structures are
shown in Figure 1a and statistics on these structures are
given in Table 2. Inclusion of a further 12 structures that
were next lowest in energy only increased the backbone
rms deviation from 0.71 to 0.74Å. The rms deviation of
the individual a-carbon atoms to the average structure is
shown in Figure 1b, which demonstrates that the struc-
tures are best defined for the helical structure elements
and least well defined for the residues at the C terminus.
A stereo view of an a-carbon trace is shown in Figure 2.
These structures are based on a larger number of NOEs
than the recently reported structure of S100A6 (calcyclin),
and hence are better defined. Analysis of the Ramachan-
dran plot shows that only 0.4% of the residues fall into
the disallowed region of the plot and no individual
residue consistently falls into this region for every one of
the 25 structures. Analysis of the average structure shows
that Asp23 in the N-terminal calcium-binding loop and
Glu86, close to the C terminus and which was not
assigned, are in locations furthest from the favoured
regions on this plot.
Structure description
As shown in Figure 3, each subunit of the S100B dimer
consists of an up-down-up-down four-helix bundle. The
pairs of helices, I + II and III + IV, are linked by two
helix-loop-helix calcium-binding loops, with a short
antiparallel b sheet between residues at the end of each
loop. Helices II and III are linked by a loop region that
contains a single turn of helix. The secondary structure 
is essentially as reported previously [17], although the
second helix is now seen to run beyond Asn37–Glu39 in
24 structures and to Asn38 in the remaining structure.
The long fourth helix starts at Phe70 in all the structures
and terminates at Ala83, as before, in 20 structures. In the
remaining five structures this helix runs to Thr81, Thr82
or Cys84.
The structures are able to account for many of the slow-
exchanging amides observed in residues whose amides
would not be predicted to be involved in secondary struc-
tures. In common with Ser24 of calbindin [14], the back-
bone oxygen of Lys28, the C-terminal residue of the first
b strand, provides the first hydrogen bond to the second
helix (to Leu32 HN) in all structures (see Fig. 4 for an
alignment of the amino-acid sequences and secondary
structures of S100B, calbindin and calcyclin). The Lys29
backbone oxygen forms a hydrogen bond to the HN of
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Figure 1
Ensemble of S100B backbone structures. (a) The family of S100B
structures were overlaid on their Ca positions using Insight II (Biosym).
Each monomer is shown in a different colour. Helices I, II,and IV are
labeled on the red monomer and helix III′ on the other (blue) monomer
(b) The root mean square deviation of the a carbons from the average
structure in the ensemble of structures is shown against the amino-
acid numbering and the secondary-structure elements.
Lys33 in 23 structures although this was not constrained in
the input data. Consistent with the longer length of the
second helix, a hydrogen bond was found from Glu34 back-
bone oxygen to Asn38 HN. The slow exchange of the HN
of Leu40 is probably caused by a hydrogen bond to Ile36
observed in 14 structures, although the aH chemical shift is
not consistent with standard helical geometry at this point.
The carbonyl of Leu40 forms hydrogen bonds with Phe43
(four structures) and Leu44 (17 structures) and could
account for the slow exchange observed at these sites. At
the N terminus of the helix running from Glu50–Ser62,
Val53 is hydrogen bonded to Glu49 in 21 structures. For
the helix from Phe70 to Ala83, the carbonyl of Asp69, the
last residue of the b strand, provides the first hydrogen
bond of the helix (to Phe73) in all structures. The Phe70 to
Met74 NH hydrogen bond present in 14 structures
accounts for the slow exchange observed at Met74. In con-
trast to the observations on calbindin [14], we found no evi-
dence for N capping of the N-terminal helix by Ser1 Og,
and in the other helices where serine or threonine is
present to provide N capping in calbindin the equivalent
residues in S100B are not capable of N capping (Lys28 and
Val52, see alignment in Fig. 4). In the C-terminal helix,
Asp69 takes the place of Ser62 in calbindin but its side
chain is not correctly oriented to hydrogen bond to Glu72,
and the latter does not show slow HN exchange.
The dimer is formed by the packing of the two C-terminal
helices against each other in an antiparallel fashion, shown
in Figure 3. These helices are packed at an angle of
154±8°, close to the value of 143±7° for calcyclin. Most of
the NOEs defining the dimer interface are between side
chains of residues in these helices. In addition, further
dimer NOEs were located between the N-terminal helices
and the residues of helix IV of the other monomer. We have
also been able to identify NOEs between residues of the
N-terminal helices and residues in the 39–40 region, which
comes close to the N terminus of the other monomer.
These are from Val7 to Leu40, Lys5 to Glu39 and Leu40,
Val77 to Leu10 and Val7, and from Thr81 to Ile11. It is
notable that many of the residues forming the dimer inter-
face are absent in calbindin, which has only 75 residues and
is a monomer in solution.
The hydrophobic core of the protein, shown in Figure 5a, is
made up of Leu10, Val13, Phe14, Leu32, Ile36, Phe43,
Val52, Val56, Leu60, Phe76 and Ile80, all of which are con-
served or conservatively substituted when compared with
calbindin. The x1 rotamer distributions of these residues
have been compared with calbindin [14]. The most signifi-
cant difference is in Val13, which is trans in S100B whereas
the equivalent residue in calbindin, Ile9, is gauche plus. The
only other differences are that Leu32 and Val56 in S100B
are always trans whereas their equivalents in calbindin
show mixed conformations. The monomer hydrophobic
core is extended by Val7, Phe70, Met74, Ala75, Ala78,
Thr82 and Phe88 so that the dimer has one continuous core
of hydrophobic residues. Of these additional residues, only
Phe70 is conserved in calbindin and shows a different
packing in that the x1 rotamer distribution is gauche plus
rather than trans, as found for Phe63 in calbindin. In S100B,
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Table 2
Summary of data on the ensemble of 25 S100B structures.
Average total energy (kcal mol–1)* 499 ± 60
Average NOE energy (kcal mol–1)† 129 ± 18
Average number of NOE violations > 0.25 Å 4.8 ± 3.3
Average number of dihedral angle violations > 5° 1.0 ± 1.5
Rms deviation for ensemble of structures  
to the average structure‡
In helices (Å) 0.71, 1.01
All residues (Å) 1.26, 1.76
*The energy term included only a repulsive van der Waals term and no
electrostatic interactions; †NOEs were scaled at 50; ‡backbone, all
heavy atoms.
Figure 2
Stereo view of the backbone of S100B. A
single member of the family of structures is
shown, with every tenth amino acid numbered.
this brings the ring of Phe70 away from the monomer to
which it is chemically bonded and into close proximity with
residues of the other monomer. If this orientation existed in
calbindin it would leave Phe63 very exposed. The unex-
pected absence of Ile47 from the hydrophobic core of the
protein is illustrated in Figure 5b.
The interhelix angles of S100B are shown in Table 3
where they are compared with those of calcyclin and cal-
bindin. Only the angle between helices II and IV differs
by greater than two standard deviations from the value for
calcyclin and this deviation is towards the value seen in
calbindin. However, by observation of the actual struc-
tures the biggest difference among these three structures
is in the location of helix III, which is much closer to being
antiparallel to helix IV in S100B than in the other two pro-
teins. The NOE contacts in this region between helix III
and the surrounding two helices are mainly hydrophobic
in nature being mediated by NOEs from Val52, Val56,
Thr59 and Leu60 on helix III to hydrophobic residues
Leu32, Phe76, Ala83 and Met79. Some NOE contacts
were also observed involving charged residues, specifically
from Leu60 to Lys29 and Lys33 side chains and from
Val56 to Glu46 but there were no obvious ion pairs.
With the larger number of NOEs used in this calculation
compared with that of the structure of calcyclin, we are able
to define the calcium-binding loops more clearly. The N-
terminal loop is made up of residues Ser18 to Glu31. This
loop is in a conformation which would be ready to bind
calcium. Important contacts which determine the structure
of this loop have been identified; for example, NOEs from
Ser18 CaH to Leu27 CaH and from Tyr17 to Leu35, the
latter defining the hydrophobic contacts across the ends of
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Figure 4
Alignment of S100B, calbindin and calcyclin
sequences and reported secondary
structures.
Figure 3
(a) (b) (c)
II
III
IV
I
Three-dimensional structure of the S100B dimer. The structure of the
backbone of S100B is shown with each of the monomers in a different
colour. (a) View with the N termini of the monomers at the front, which
is comparable with the views shown in Figures 1 and 2. (b) View from
the reverse side showing the contact of the helices IV and IV′ which
make up the bulk of the dimer interface. (c) View from the top of the
structure relative to (a), showing the way in which the two N-terminal
helices cross over each other.
the calcium-binding loop. The calcium ligands of this loop
are mainly backbone carbonyls and those from Ser18,
Asp23 and Lys26 are all pointed towards the centre of the
loop. In addition, the bidentate ligand from the side-chain
carboxylate of Glu31 points back into the calcium loop, as
illustrated in Figure 5. Only the carbonyl of Glu21 is not
oriented correctly for calcium ligation.
In contrast, the C-terminal calcium-binding loop takes up
a different form. The third long helix is oriented differ-
ently to that of calcium-free calbindin. It is almost antipar-
allel to the fourth helix, with its residues further away from
the b strand at the end of the calcium-binding loop. NOEs
which would be expected by reference to the structure of
calcium-free calbindin [14] to define the C-terminal EF-
hand type calcium-binding loop were found to be absent.
In particular, NOEs from Cys68 CaH and CbH2 to Leu60
CdH3 and CbH were absent as were the NOEs from
Asp61 CaH and CbH2 to Cys68 CaH. All these NOEs are
between well resolved resonances and would be visible
even in 2D spectra. Closer examination of the loop shows
that three of the calcium-binding ligands, the side chain of
Asp63, the carbonyl of Glu67 and the side chain of Glu72,
are well placed for calcium binding. However, the remain-
ing ligands, the side chains of Asp61 and Asp65, point
away from the loop and would need to change conforma-
tion to bind calcium (Fig. 5d).
Discussion
The determination of the structure of the S100B dimer
confirms that the novel overall dimer structure found
recently for calcyclin [10] is the common fold for the
dimeric S100 proteins. We found that the same residues
along the C-terminal helix and several residues on the N-
terminal helix make up the majority of the contacts that
define the interface. Residues that are most important in
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Figure 5
Structural features of S100B. (a) The amino
acid side chains that make up the
hydrophobic core of S100B in the ensemble
of structures are shown with each monomer
coloured differently. Note the way in which the
hydrophobic cores of the monomers are
joined into one in the dimer. (b) The backbone
structure of S100B is shown with the side
chains of the cysteines in yellow and Ile47 in
green. (c) The N-terminal calcium-binding
loop. Only the backbone and the side chain of
Glu31 is shown with the predicted potential
oxygen ligands for the calcium ion shown in
red. (d) The C-terminal binding loop.
Residues 59–75 are shown as backbone,
with side chains of Asp61, Asp63, Asp65,
Glu67 and Glu72. Potential oxygen ligands
for calcium are shown in red.
Table 3
Comparision of the helix angles in S100B with calbindin and
calcyclin (S100A6).
Helices S100B Calcyclin Calbindin
I–II 129.5° ± 3.4° 126° ± 27° 123° ± 3°
I–III –66.5° ± 2.4° –83° ± 22° –109° ± 9°
I–IV 118.6° ± 2.2° 119° ± 17° 128° ± 4°
II–III 143.6° ± 2.9° 144° ± 15° 124° ± 7°
II–IV –46.4° ± 3.2° –16° ± 10° –34° ± 4°
III–IV 164.3° ± 4.0° 145° ± 16° 118° ± 8°
IV–IV′ 154.6° ± 8.6° 143° ± 7° –
defining this surface are Thr82, Phe70, Thr81, Phe88,
Phe87 from near to the C terminus and residues Ile11 and
Phe14 from the N-terminal helix. A few residues from the
N terminus also show NOEs to residues Glu39 and Leu40.
It is notable that these two residues are conserved in almost
all S100 group proteins. These NOEs define the location of
the N-terminal helix in a way that was not identified for cal-
cyclin, and as a result the structure reported here for S100B
is more compact than that reported for calcyclin, with the
N-terminal helices closer to the main core of the dimer.
The surface of S100B is characterized by many charged
residues. The spread of charged residues, predominantly
negatively charged, is quite even over the face of the dimer
that is shown in Figure 6a. On the opposite side (Fig. 6b)
there is a much stronger concentration of negative charges,
especially in a cleft in the centre of the molecule: as noted
in calcyclin [10], this is a potential binding cleft. In space-
filling models no hydrophobic residues are even partly
visible on this side. However, despite the high level of
surface charges on S100B and its high solubility in water,
there are several hydrophobic residues exposed on the
surface. Most notably, Ile47 is very exposed in the loop
region between helices II and III (Fig. 5b). Observation of
the NOEs to Ile47 CdH3 and CgH3 show none from the
aromatic protons of Phe43, or from the methyl groups of
Val52 and Val53, which are the residues of the hydrophobic
core in this region of the protein. Another residue which 
is partly exposed is Val8. It is notable that hydrophobic
residues are not normally present at these locations in other
S100 proteins. Leu44 and Val53 are also partly exposed.
Several regions of the molecules of the S100 family have
been proposed to interact with their effector molecules,
and knowledge of the structure of S100B allows us to
comment on the likelihood of the interaction at each of
these locations. S100B forms disulphide bridges to tau
protein through either Cys68 or Cys84 [21]. Amino acids
four to seven at the N terminus of calcyclin, are suggested
to bind to annexin XI. [22] A peptide from S100A8 (CP–10)
corresponding to the region between the second and third
predicted helices mimicked most of the cytokine effect of
the whole protein upon phagocytic cells [23]. These pro-
posed binding sites near the N terminus and on the loop
between helices II and III are consistent with the structure,
as both of these regions are exposed and are also the least
well conserved regions of the protein. In addition, they also
both contain exposed hydrophobic residues, as noted
above. In the case of S100A10 (p11), the binding site of
annexin II on S100A10 has been suggested to involve the
residues 85–91 and in particular the residues Tyr85 and
Phe86 [24]. However, these residues (equivalent to Phe87
and Phe88 in S100B) are buried in the dimer interface in
S100B and are crucial to the hydrophobic core of the dimer.
The loss of binding upon mutation of these residues may
therefore be due to the disruption of the dimer structure
rather than to specific loss of the binding site for annexin
II. We have recently observed significant chemical-shift
changes in the spectrum of 15N-labelled S100B when it
binds to neurocalcin d, a member of the recoverin family of
calcium-binding proteins [25], and are currently using these
changes to determine the binding site of neurocalcin d on
the S100B dimer.
This structure also has implications for the activity of
S100B as a neurite-extension factor. S100B is only active in
this assay when calcium is bound and when S100B is in a
disulphide-bridged form. It has not yet been established
whether this disulphide bridge is intradimer or interdimer.
The structure of S100B shows that Cys68 is about 21 Å
away from Cys84 on the other monomer and a substantial
structural rearrangement of the C terminus would be
required to form disulphide bridges within the dimer struc-
ture. Disulphide-bridge formation between two dimers in
the absence of calcium would be unlikely to involve Cys68
as the side chain of this residue points into the core of the
molecule, but Cys84 is more exposed and could therefore
form a disulphide bridge in this way (Fig. 5b).
1048 Structure 1996, Vol 4 No 9
Figure 6
GRASP [37] diagram of the S100B surface
charges (ranging from –15 [red] to +22
[blue]): (a) view as in Figure 3a; (b) view as in
Figure 3b.
We can also comment on the effect of calcium on the
S100B dimer. Clearly the apoprotein structure shows that
the C-terminal calcium-binding loop is not correctly
formed for calcium binding. Several of the calcium-ligand-
ing side chains do not point to the calcium-binding site
and the angle between helices III and IV is larger than we
would expect even in a closed form of a calcium-binding
protein. If the C-terminal calcium-binding loop, as we
would expect, formed a classical EF-hand structure on
binding calcium, then helix III would move significantly
with respect to helices II and IV. Such a change in confor-
mation might be the signal by which S100B proteins are
activated to bind to their effector molecules. It might also
be that the conformational changes in S100 proteins that
are calcium regulated are different from the calcium buffer
calbindin and more similar to the regulatory domains of
calmodulin or troponin C. In these latter proteins, when
calcium is bound the whole domain changes shape to an
open form with exposed hydrophobic surfaces. If such a
change takes place in S100B, it might bring together one
cysteine from each monomer to form an intermonomer
disulphide bridge. The answers to these questions await
our structural studies on calcium-bound S100B, which are
currently in progress.
Biological implications
S100B (S100b) is a member of the S100 family of low
molecular weight (10–12 kDa) calcium-binding proteins.
S100B is a neurite-extension factor and interacts with
several cytoskeletal proteins and protein kinases. The
other S100 proteins interact, in a calcium-dependent
manner, with a wide range of proteins involved mainly
in the cytoskeleton and in cell proliferation.
In order to understand the calcium activation and
interactions of S100 proteins, knowledge about their
three-dimensional structures is essential. Of the S100
proteins, structures have only been reported for the
monomeric calbindin D9k, which lacks N- and C-termi-
nal hydrophobic regions, and recently S100A6 (calcy-
clin) at relatively low resolution. We have now
determined the structure of the S100B dimer in the
calcium-free state.
The main structural difference between S100B and cal-
bindin D9k is in the location of the third helix. In S100B
this helix is almost antiparallel to the fourth helix
whereas in calbindin the third helix is tilted 40° further
away from antiparallel. As a consequence of this, the
C-terminal calcium-binding loop in S100B, which is
between these helices, is not in a conformation ready to
bind calcium. We expect that calcium binding will cause
changes in the conformation of this loop. The dimer is
formed by antiparallel packing of the two C-terminal
helices against each other so that the hydrophobic core
extends through the dimer interface.
The structure shows the regions through which S100
proteins are predicted to interact with their target pro-
teins. For example, S100B binds to tau protein through
a cysteine, and of the two cysteines, only Cys84 is
exposed. In contrast, residues equivalent to Phe87 and
Phe88, which are buried in the dimer interface of
S100B, have been reported to be crucial for binding of
S100A10 (p11) to annexin II. These residues are proba-
bly important for dimer formation. However, detailed
knowledge of S100–effector binding awaits the determi-
nation of the structures of calcium-bound S100B and its
effector complexes.
Materials and methods
Sample preparation
Two samples of [13C,15N]-labelled S100B were prepared. Each was
expressed and purified from E. coli as described previously [17] with
the following modifications. Labelling was carried out in 2 litres of
2 ×M9 media which contained 1 g l–1 of uniformly labelled 13C-glucose
(Isotec) as the sole carbon source and 2 g l–1 of 15NH4Cl (Isotec) as
sole nitrogen source. Cultures were induced at an OD600 of 0.4 for 3 h.
The two NMR samples were made up in buffer solution as before, one
in 90 % H2O:10 % 2H2O at pH 6.5 and the other in 99.99 % 2H2O at
pH 6.3 (uncorrected meter reading). Both samples were at a concen-
tration of 1.7 mM and contained 2 mM deuterated EDTA.
NMR spectroscopy
3D HNCA [26] and HCCH-TOCSY [27] experiments were acquired
on a Bruker AMX600 spectrometer. 3D CBCA(CO)NH [26] and 13C-
edited NOESY-HMQC [28] experiments (100 ms mixing time), opti-
mized for detection of NOEs to aliphatic or aromatic protons, were
acquired on a Bruker DMX 500 spectrometer. 2D double quantum fil-
tered correlation spectroscopy (COSY) [29] and NOESY [30] were
acquired a Bruker AM500 spectrometer. The HNCA experiment was
acquired in 512 ×34 ×52 (1H,15N,13C) complex points using States
quadrature detection in the 15N and 13C dimensions and transformed
to a matrix of 256 ×256 ×128 points. The HCCH-TOCSY was
acquired in 2048 ×70 ×200 (1H,13C,1H) real points using time propor-
tional phase incrementation (TPPI) for quadrature detection of indi-
rectly acquired dimensions and processed with zero filling to
512 ×128 ×256 real points. The 3D 13C-filtered NOESY-HMQC exper-
iments were acquired in 2048 ×70 ×200 (1H,13C,1H) real points and all
processed in a similar manner with zero filling to matrices of
256 ×128 ×512 points. In the NOESY-HMQC experiment to detect
NOEs to aliphatic protons the 13C dimension was folded once and the
experiment processed twice with different phasing parameters in the
13C dimension to permit analysis of the differently phased sets of
peaks. Window functions were Gaussian (Gaussian broadening of
0.12 Hz and linebroadening of –12 Hz) in the acquisition dimension
and sine-squared (70° shift) in the other dimensions. 
Peak picking and volume integration
Peaks were picked automatically in Felix 2.3.0 software (Biosym).
Volumes of peaks in the 3D spectra were measured using in house
software interfaced to Felix [31].
Resonance assignments
Assignments of the 13C Ca and Cb shifts of the protein were made from
the CBCA(CO)NH and HNCA experiments. Other 13C shifts and assign-
ments of the aromatic proton chemical shifts were made from the 13C-
edited NOESY-HMQC experiments. Assignments were transferred from
the assignment table, using an awk script, to the picked peaks of the
NOESY experiments using different tolerances: ±0.02 ppm for the 1H
acquisition dimension, ±0.4 ppm for 13C or 15N and ±0.04 for the indi-
rectly acquired 1H dimension. NOE destination nuclei were assigned if
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both the 1H and heteronuclear chemical shifts matched the table of
assignments. NOE origin chemical shifts were assigned to any nucleus
that had a chemical shift within the specified range. NOEs were consid-
ered unique if the origin and destination nuclei were each assigned to
only one set of magnetically equivalent nuclei. If two or more possibilities
existed NOEs were treated as ambiguous. The database was then edited
so that any intraresidue, sequential or secondary-structure defining NOEs
were assigned uniquely.
Calibration of distances
Distances were calibrated using a line of best fit through a plot of
volume against 1/r6 for sets of fixed distances or distances that can be
defined by the secondary structure. Upper limits were set at the greater
of either two standard deviations or 20% greater than the target dis-
tance. The standard deviations are the deviations of the NOE-derived
distances to their corresponding fixed distances. Lower limits were set
at 40 % less than the target distance. Uniquely assigned NOE volumes
were corrected to permit the use of centre-averaged restraints. Ambigu-
ously assigned NOEs were not corrected and for these sum averaging
was used.
Structure calculation
Structures of S100B were calculated using the distance geometry sim-
ulated annealing protocol in X-PLOR [32]. The structure of the
monomer was first determined using the uniquely assigned intramolecu-
lar NOEs. The method for this is described in the dg_sub_embed.inp
and dgsa.inp protocols in the X-PLOR manual. The input dataset con-
sisted of 588 intraresidue; 199 sequential; 28 i,i+2; 65 i,i+3; 4 i,i+4;
and 20 long range uniquely assigned NOE restraints. There were 35
hydrogen-bond restraints of 2.05± 0.25Å for the a helices that we had
identified previously [17] and one for the b sheet. Weak dihedral angle
constraints of ϕ= –60± 30°, ψ= –40± 60° for 60 residues in helices
and ϕ = –120± 30°, ψ = –120± 60° for seven residues in b-strands
were included [10]. These constraints were included for helical residues
only where the aH chemical-shift indices predicted helical structure and
when double quantum filtered COSY HN-aH crosspeaks were weak.
For b-strand structure these constraints were included where aH chem-
ical-shift indices predicted helical structure and when double quantum
filtered COSY HN-aH crosspeaks were strong and showed large cou-
pling constants. On the basis of these calculations, a further 14
intraresidue; 16 sequential; 3 i,i+2; 5 i,i+3; 6 i,i+4; and 26 long-range
constraints were resolved from the ambiguous data and added to the
calculation. These were only resolved if no other possible assignment
was within the greater of 12Å or twice the shortest assignable distance
and only if the prospective assignment was within 7Å in the initial struc-
tures. The monomer structures were then recalculated and refined twice
using simulated annealing (8000 steps, 40ps, cooled from 2000°C,
using the refine.inp protocol from the X-PLOR manual). Of the 80 initial
structures, the 39 lowest energy monomer structures (all the structures
of less than 1000kcal mol–1 total energy) were used in subsequent cal-
culations. In this process, several NOEs that were inconsistent with the
structure were put aside as a set of intermonomer NOEs.
Each monomer structure was duplicated and rotated about helix IV by
180° and about an axis running through the centre of helices II and IV by
180°. The choice of axes for rotation was made to be consistent with the
uniquely assigned intermonomer NOEs which were from one end to the
other of helix IV, specifically between residues Phe70 and Thr82, Gln71
and Thr82, Gln71 and Ala78, and Phe70 and Phe88. The monomers
were then separated by 20Å along the latter axis. The two monomers
were docked using simulated annealing by gradually increasing the scale
factor of the dimer set of five NOEs, which were specifically assigned as
intermonomer, from 1–50 exponentially over 2000 steps (10 ps) at
2000°C and then cooling the structure for a further 2000 steps (10 ps).
These structures were then refined (12000 steps, 60ps) with gradual
(exponential) inclusion of the ambiguous NOEs that were not defined to
be either intra- or intermonomer. At this stage noncrystalline symmetry
was gradually introduced from a weight of 0.1–10kcal mol–1 Å–2.
In these calculations, two conformations of the dimer appeared. In the
first case, which almost always had the lower energy, the N-terminal
helix protruded from each monomer and ran under the equivalent helix
on the other monomer. This form of the dimer was formed for 19 out of
34 structures and was the most similar to the monomer structures: the
N-terminal helix points away from the other helices. In the second case,
which was less common (15 structures) and in all but five cases gener-
ated structures with a higher energy than any structure of the first con-
formation, the two monomers were docked with the first and fourth
helices alongside and parallel to each other and running antiparallel to
the equivalent helices on the other monomer. These structures were
not favoured on energetic grounds, or on the basis of the experimental
data as the most clearly observed intermonomer NOEs do not involve
NOEs from one end to the other of the first helix. In addition, we did not
find any long-range NOEs from the first ten amino acids on helix I to
residues on helix IV of the same monomer, and the initial monomer cal-
culations showed that helices I and IV do not run parallel to each other.
On the basis of this set of 19 structures, 19 further ambiguous inter-
monomer restraints were uniquely assigned. These were only assigned
if one pair of possible nuclei made the shortest assignable distance in
all 19 structures. These NOEs were included in subsequent calcula-
tions as uniquely assigned intermonomer NOEs.
100 further monomer structures were then calculated and the 52
lowest-energy structures (all the structures with total energies of less
than 1000kcalmol–1) from this set docked in the same way as before.
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Table 4
NOEs used in the calculation of the structure of S100B*.
First distance Additional NOEs Additional NOEs Totals for first Total NOEs 
geometry stage for monomer for dimer dimer for final
calculations calculations refinement refinements
Intraresidue 588 14 602 694
Sequential 199 16 215 278
i,i+2 28 3 31 53
i,i+3 65 5 68 130
i,i+4 4 6 10 47
Long range 20 26 46 169
Intermonomer 5 5 30
Ambiguous 666 274†
*Numbers of NOEs are given as per monomer. The actual numbers of
NOEs which are used in the calculations are twice this. †Of these
NOEs, 119 are uniquely assigned by the final set of 25 structures into
five intraresidue NOEs; 15 sequential; 8 i,i+2; 16 i,i+3; 8 i,i+4; 22 long
range and 11 intermonomer NOEs. The remaining 155 NOEs were not
uniquely assigned in all the structures.
The full set of 52 new and 39 original docked dimer structures were
refined by cooling from 2000°C (6000 steps, 30 ps) twice with a loga-
rithmic increase in the weight of the noncrystalline symmetry from 0.1 to
10 kcalmol–1 Å–2. Finally the ambiguous NOEs were resolved using the
set of 25 lowest-energy structures. This resolved 365 NOEs and left
274 NOEs ambiguous in the final calculations. The 365 NOEs were
assigned as 92 intraresidue, 63 sequential, 22 i,i+2, 62 i,i+3, 37 i,i+4,
83 long range and 6 intermonomer. A list of the NOE constraints used
in the calculations is given in Table 4. An NOE was resolved (assigned
as unique) only if it was assigned to the same set of atoms in all of the
structures and not violated by on average more than 0.15 Å. The calcu-
lations were then repeated from the point were the ambiguous NOEs
were included.
To confirm the use of the hydrogen-bond constraints in the input data,
another experiment and some further calculations were performed. The
amide-exchange experiment was carried out upon a sample of 1 mM
15N-labelled S100B at 306 K and pH 6.3, using 20 mM KH2PO4 buffer
in addition to the normal buffer components to control the pH during
lyophilisation. A further set of 90 monomer structures was generated
as before without hydrogen-bond constraints. Hydrogen-bond con-
straints were only added to subsequent stages of the calculation for
residues that showed slow or intermediate exchange and if the pre-
dicted hydrogen-bond distances violated the possible constraints by an
average of less than 0.5 Å in the set of 31 lowest energy monomer
structures. These monomers were refined, docked and reannealed as
before with the addition of several further hydrogen bonds that subse-
quently satisfied the conditions above when constraints from the
ambiguous NOEs were included. In this way, all of the previous hydro-
gen bonds were included in the set of structures except for those
between residues 3–7 (0.53 Å distance violation), 8–12 (0.91 Å dis-
tance violation), 11–15 (not justified by hydrogen exchange data),
41–45 (0.56 Å distance violation) and 58–62 (no distance violation but
not justified by the exchange data). As expected, the resulting struc-
tures were not significantly different from the first set.
Structures were accepted for inclusion in the final family solely on the
basis of their total energies. Structures were analyzed using the
PROCHECK-NMR package for secondary structure and f, ψ, and χ1
angles [33]. Hydrogen bonds were located using the HBOND program
in the CCP4 package [34]. This program uses an electrostatic calcula-
tion of the hydrogen-bond energy [35]. All hydrogen bonds with ener-
gies of less than –1.27 kcal mol–1 (i.e. stronger than –1.27 kcal mol–1)
were calculated. This energy corresponds to a hydrogen bond with H
to O distance of 2.50 Å and a N–H...O angle of 135°, where N and
O=C are colinear.
To compare the structure of the C-terminal EF hand with calbindin, the
sequence of S100B was modelled onto the structure of calbindin [14]
in the calcium-free state, using the program Modeller [36].
Accession numbers
The coordinates of the ensemble of structures have been deposited at
the Brookhaven Protein Data Bank under the accession code 1cfp.
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